1 Previous year figures have been regrouped/ recast/ rearranged
wherever necessary to conform to current year classification.
2 CONTINGENT LIABILITIES :
(Rs. in Lakhs)
Particulars 2010-11 2009-10
i) On account of Letters of Credit and
Guarantees issued by the bankers. 3510.49 4404.68
ii) On account of bonds and / or legal
agreements executed with Central Excise/
Customs authorities/ Development
Commissioners 10750.00 7250.00
iii) Demands being disputed / contested
by the Company 1768.86 1778.64
3 Estimated amount of contracts remaining to be executed on capital
account and 5501.22 691.96 not provided for (Net of advances)
4 Land admeasuring 29.30 acres acquired under deeds of assignment and
under possession of the company at Chippada village, Bheemunipatnam
Mandal, Visakhapatnam Dist. is yet to be registered in the name of the
company.
5 Excise duty on sales for the year has been disclosed as reduction
from turnover. Excise duty relating to the difference between closing
stock and opening stock has been included in Schedule 23 (Increase) in
Stocks.
6 EMPLOYEE STOCK OPTION SCHEME :
In respect of Options granted to employees during the year 2005-06
under the Employees Stock Option Scheme, in accordance with the
guidelines issued by Securities and Exchange Board of India, the
accounting value of Options, determined based on market price of the
share on the day of the grant of the Option, is accounted as Deferred
Employee Compensation Costs and the same is being amortised on straight
line basis over the vesting period of Stock Options. Consequently for
the Current Year, an amount of Rs. Nil/-(Previous year Rs. 225.70
Lakhs) has been amortised.
7 CALCULATION OF COMMISSION :
Computation of Net Profit in accordance with Section 349 read with
section 198 of the Companies Act, 1956 with relevant details of the
calculation of commission payable by way of percentage of such Profits
to Chairman and Managing Director, Executive Director and Director
(Business development) for the year ending 31st March, 2011.
8 SEGMENTAL REPORTING :
(i) As the Companys business for the year consists of one reportable
business segment of manufacturing and sale of Active Pharma Ingredients
and Intermediates and consists of major revenue on account of exports
out of India, no separate disclosures pertaining to attributable
Revenues, Profits, Assets, Liabilities and Capital Employed are given.
9 TRANSACTIONS WITH RELATED PARTIES :
a) The List of Related Parties with whom transactions have taken place
and nature of relationship is:
i) KEY MANAGEMENT PERSONNEL :
1. Dr. Murali. K. Divi
2. Mr. N.V. Ramana
3. Dr. P. Gundu Rao
4. Mr. D. Madhusudana Rao
5. Mr. Kiran S. Divi
ii) RELATIVES OF KEY MANAGEMENT PERSONNEL :
1. Mr. N. Laxmana Rao
2. Mr. Mallikarjuna Rao Divi
3. Mrs. Nilima Motaparti
(iii) SUBSIDIARIES:
1. Divis Laboratories (USA) Inc
2. Divis Laboratories EUROPE AG
10 ADVANCES TO SUBSIDIARIES :
a. The Company has undertaken to provide financial assistance to its
wholly owned subsidiaries Viz., Divis Laboratories (USA) Inc., and
Divis Laboratories Europe AG by way of loans with no specific
repayment schedule. In respect of loan to Divis Laboratories Europe
AG, the same is subordinated to other creditors to the extent of CHF
40,00,000 equivalent to Rs.1952.00 Lakhs (Previous year CHF 40.00 Lakhs
equivalent to Rs. 1695.60 Lakhs)
11 DERIVATIVE INSTRUMENTS :
a. The Company uses foreign exchange forward contracts and options to
hedge its foreign currency exposures relating to the underlying
transactions and firm commitments, to reduce the foreign exchange
fluctuation risk or cost to the Company. The Company does not use these
derivative instruments for trading and speculative purposes.
d. The losses on account of Exchange difference on Foreign Currency
Forward Contracts and Options have been fully provided for in the books
of accounts and the outstanding provision for loss at the year end is
Rs 893.78 Lakhs (Previous year Rs.1,527.56 Lakhs).
-MIn the opinion of management the current assets, loans and advances
are expected to realise the value stated in the accounts, in the
ordinary course of business and provision for known liabilities has
been made.
-The Ministry of Corporate Affairs, Government of India, vide General
Circular No. 2 and 3 dated 8th February 2011 and 21st February 2011
respectively has granted a general exemption from compliance with
section 212 of the Companies Act, 1956, subject to fulfillment of
conditions stipulated in the circular. The Company has satisfied the
conditions stipulated in the circular and hence is entitled to
exemption. Necessary information relating to the subsidiaries has been
included in Consolidated Financial Statements.
12 The schedules referred to in the Balance sheet form an integral part
of Accounts. Additional information as required under Part – IV to
Schedule VI of the Companies Act, 1956 is given in Annexure.
|